AptarGroup Inc (ATR) Actualités

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a...

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

SmartTrack™ aims to reduce the need for clinical studies in generic drug product approvals AptarGroup, Inc...

Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year

Places in top 1% of EcoVadis’ rankings for all industries AptarGroup, Inc. (NYSE: ATR), a global leader in...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities